Tabo-tabo, Petra A.

HRN: 25-11-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
CEFTRIAXONE 1G (VIAL)
06/22/2026
06/29/2026
IVTT
2g
Q24H
CAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: